Ascentage Pharma Group International (AAPG) Shares Outstanding (2023 - 2026)

Ascentage Pharma Group International's Shares Outstanding (Entity) history runs 4 years deep, the most recent figure standing at $373.3 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Entity) rose 7.19% year-over-year to $373.3 million; the TTM figure through Dec 2025 stood at $373.3 million (up 7.19% YoY), while the FY2025 annual figure was $373.3 million, up 7.19% from the prior year.
• Shares Outstanding (Entity) for Q4 2025 stood at $373.3 million, up from $348.3 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $373.3 million in Q4 2025, with the low at $265.2 million in Q4 2022.
• The 4-year median for Shares Outstanding (Entity) is $319.2 million (2023), against an average of $319.2 million.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) grew 20.01% in 2024, then advanced 7.19% in 2025.
• Ascentage Pharma Group International's Shares Outstanding (Entity) stood at $265.2 million in 2022, then gained by 9.43% to $290.2 million in 2023, then rose by 20.01% to $348.3 million in 2024, then climbed by 7.19% to $373.3 million in 2025.
• Business Quant data shows AAPG's Shares Outstanding (Entity) at $373.3 million in Q4 2025, $348.3 million in Q4 2024, and $290.2 million in Q4 2023.